Interleukin-6 regulates pancreatic α-cell mass expansion
- 2 September 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (35), 13163-13168
- https://doi.org/10.1073/pnas.0801059105
Abstract
Interleukin-6 (IL-6) is systemically elevated in obesity and is a predictive factor to develop type 2 diabetes. Pancreatic islet pathology in type 2 diabetes is characterized by reduced beta-cell function and mass, an increased proportion of a-cells relative to p-cells, and a-cell dysfunction. Here we show that the a cell is a primary target of IL-6 actions. Beginning with investigating the tissue-specific expression pattern of the IL-6 receptor (IL-6R) in both mice and rats, we find the highest expression of the IL-6R in the endocrine pancreas, with highest expression on the a-cell. The islet IL-6R is functional, and IL-6 acutely regulates both pro-glucagon mRNA and glucagon secretion in mouse and human islets, with no acute effect on insulin secretion. Furthermore, IL-6 stimulates a-cell proliferation, prevents apoptosis due to metabolic stress, and regulates a-cell mass in vivo. Using IL-6 KO mice fed a high-fat diet, we find that IL-6 is necessary for high-fat diet-induced increased a-cell mass, an effect that occurs early in response to diet change. Further, after high-fat diet feeding, IL-6 KO mice without expansion of a-cell mass display decreased fasting glucagon levels. However, despite these a-cell effects, high-fat feeding of IL-6 KO mice results in increased fed glycemia due to impaired insulin secretion, with unchanged insulin sensitivity and similar body weights. Thus, we conclude that IL-6 is necessary for the expansion of pancreatic a-cell mass in response to high-fat diet feeding, and we suggest that this expansion may be needed for functional beta-cell compensation to increased metabolic demand.Keywords
This publication has 38 references indexed in Scilit:
- Specificity in Beta Cell Expression of l-3-Hydroxyacyl-CoA Dehydrogenase, Short Chain, and Potential Role in Down-regulating Insulin ReleasePublished by Elsevier BV ,2007
- The Fas pathway is involved in pancreatic β cell secretory functionProceedings of the National Academy of Sciences of the United States of America, 2007
- Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasisJournal of Applied Physiology, 2007
- COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASISJournal of Applied Physiology, 2007
- Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell FunctionDiabetes, 2006
- Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesityAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Expression of Interleukin-6, Interleukin-6 Receptor (gp80), and the Receptor's Signal-Transducing Subunit (gp130) in Human Normal Pituitary Glands and Pituitary AdenomasLaboratory Investigation, 2001
- Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xLPublished by Elsevier BV ,2001
- Differences in aggregation properties and levels of the neural cell adhesion molecule (NCAM) between islet cell typesExperimental Cell Research, 1990
- Autofluorescence-activated cell sorting of pancreatic islet cells: Purification of insulin-containing B-cells according to glucose-induced changes in cellular redox stateBiochemical and Biophysical Research Communications, 1983